Overview

Mass Balance Recovery and Metabolite Identification of Carbon-14 BIA 28-6156

Status:
Completed
Trial end date:
2021-10-16
Target enrollment:
Participant gender:
Summary
The study is designed to determine the absorption, distribution, metabolism and elimination (ADME) of BIA 28-6156 in humans, further explore the PK of BIA 28-6156, evaluate the extent of distribution of total radioactivity into blood cells, provide additional safety and tolerability information and collect samples for metabolite profiling and structural identification.
Phase:
Phase 1
Details
Lead Sponsor:
Bial R&D Investments, S.A.